05/09/2024
5:58 PM | Amgen (Issuer)
Bradway Robert A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
5:59 PM | Amgen (Issuer)
Bradner James E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
6:00 PM | Amgen (Issuer)
Busch Matthew C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
6:02 PM | Amgen (Issuer)
Gordon Murdo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
6:03 PM | Amgen (Issuer)
Graham Jonathan P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
6:04 PM | Amgen (Issuer)
Griffith Peter H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
6:05 PM | Amgen (Issuer)
Grygiel Nancy A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
05/09/2024
6:06 PM | Amgen (Issuer)
Khosla Rachna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
6:07 PM | Amgen (Issuer)
Miller Derek (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
6:07 PM | Amgen (Issuer)
REESE DAVID M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
6:08 PM | Amgen (Issuer)
Santos Esteban (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2024
6:56 PM | Amgen (Issuer)
Drake Michael V (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2024
6:57 PM | Amgen (Issuer)
HOLLEY CHARLES M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2024
6:58 PM | Amgen (Issuer)
ISHRAK OMAR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
7:30 PM | Amgen (Issuer)
Bradway Robert A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
7:31 PM | Amgen (Issuer)
Busch Matthew C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
7:32 PM | Amgen (Issuer)
Gordon Murdo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
7:33 PM | Amgen (Issuer)
Graham Jonathan P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
7:34 PM | Amgen (Issuer)
Griffith Peter H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
7:35 PM | Amgen (Issuer)
Grygiel Nancy A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
7:36 PM | Amgen (Issuer)
Khosla Rachna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
7:36 PM | Amgen (Issuer)
Miller Derek (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
7:37 PM | Amgen (Issuer)
REESE DAVID M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
7:39 PM | Amgen (Issuer)
Santos Esteban (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2024
7:23 PM | Amgen (Issuer)
Bradway Robert A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2024
7:24 PM | Amgen (Issuer)
Busch Matthew C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2024
7:25 PM | Amgen (Issuer)
Khosla Rachna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
6:48 PM | Amgen (Issuer)
Grygiel Nancy A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
6:17 PM | Amgen (Subject)
Grygiel Nancy A. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/03/2024
6:18 PM | Amgen (Issuer)
Gordon Murdo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
6:19 PM | Amgen (Issuer)
Graham Jonathan P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
6:20 PM | Amgen (Issuer)
Griffith Peter H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
6:22 PM | Amgen (Issuer)
Grygiel Nancy A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
6:23 PM | Amgen (Issuer)
Miller Derek (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
6:24 PM | Amgen (Issuer)
REESE DAVID M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
6:25 PM | Amgen (Issuer)
Santos Esteban (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2024
6:59 PM | Amgen (Issuer)
Graham Jonathan P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2024
7:00 PM | Amgen (Issuer)
Khosla Rachna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2024
7:01 PM | Amgen (Issuer)
Miller Derek (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2024
7:44 PM | Amgen (Issuer)
Grygiel Nancy A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2024
6:50 PM | Amgen (Issuer)
Bradway Robert A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
The Only Energy Play You Should Be Looking At (Ad) Open AI’s Sam Altman recently helped this company raise $577 million in funding…
What’s more is, It has already inked deals with the Department of Energy. Click here to get all the information about it. |
05/01/2024
6:50 PM | Amgen (Issuer)
Busch Matthew C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2024
6:51 PM | Amgen (Issuer)
Gordon Murdo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2024
6:53 PM | Amgen (Issuer)
Griffith Peter H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2024
6:54 PM | Amgen (Issuer)
REESE DAVID M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2024
6:55 PM | Amgen (Issuer)
Santos Esteban (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
7:04 PM | Amgen (Issuer)
Graham Jonathan P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
7:05 PM | Amgen (Issuer)
Griffith Peter H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
7:07 PM | Amgen (Issuer)
Grygiel Nancy A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
7:09 PM | Amgen (Issuer)
Khosla Rachna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
7:10 PM | Amgen (Issuer)
Miller Derek (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
7:11 PM | Amgen (Issuer)
REESE DAVID M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
7:12 PM | Amgen (Issuer)
Santos Esteban (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
6:58 PM | Amgen (Issuer)
Bradway Robert A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
6:59 PM | Amgen (Issuer)
Busch Matthew C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
7:00 PM | Amgen (Issuer)
Gordon Murdo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:34 PM | Amgen (Issuer)
Santos Esteban (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:24 PM | Amgen (Issuer)
Busch Matthew C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:25 PM | Amgen (Issuer)
Gordon Murdo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:26 PM | Amgen (Issuer)
Graham Jonathan P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:27 PM | Amgen (Issuer)
Griffith Peter H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:29 PM | Amgen (Issuer)
Grygiel Nancy A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:30 PM | Amgen (Issuer)
Khosla Rachna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:31 PM | Amgen (Issuer)
Miller Derek (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:32 PM | Amgen (Issuer)
REESE DAVID M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:23 PM | Amgen (Issuer)
Bradway Robert A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
3:23 PM | Amgen (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/12/2024
6:50 PM | Amgen (Issuer)
Bradner James E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
10:35 AM | Amgen (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
12/19/2023
7:38 PM | Amgen (Issuer)
Bradner James E. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/14/2023
8:16 AM | Amgen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/04/2023
6:40 PM | Amgen (Subject)
Grygiel Nancy A. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/04/2023
6:41 PM | Amgen (Issuer)
Grygiel Nancy A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/29/2023
7:44 PM | Amgen (Issuer)
REESE DAVID M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2023
7:30 PM | Amgen (Issuer)
Graham Jonathan P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2023
1:11 PM | Amgen (Subject)
Graham Jonathan P (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/07/2023
7:06 PM | Amgen (Issuer)
Drake Michael V (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2023
7:09 PM | Amgen (Issuer)
HOLLEY CHARLES M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2023
7:10 PM | Amgen (Issuer)
ISHRAK OMAR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2023
7:12 PM | Amgen (Issuer)
Busch Matthew C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2023
7:15 PM | Amgen (Issuer)
Grygiel Nancy A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2023
7:16 PM | Amgen (Issuer)
Khosla Rachna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2023
7:20 PM | Amgen (Issuer)
Miller Derek (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2023
6:43 PM | Amgen (Issuer)
Graham Jonathan P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2023
6:44 PM | Amgen (Issuer)
Griffith Peter H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/31/2023
6:15 AM | Amgen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/06/2023
3:35 PM | Amgen (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
10/05/2023
6:43 AM | Amgen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2023
6:30 AM | Amgen (Filed by)
Neumora Therapeutics, Inc. (Subject)
| Form SC 13D | |
09/19/2023
6:52 PM | Amgen (Reporting)
Neumora Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/14/2023
5:58 PM | Amgen (Reporting)
Neumora Therapeutics, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
Dems have chosen Biden replacement? (Ad) On November 16, 2023…
Joe Biden accidentally revealed the name of the candidate…
Who will replace him in the 2024 presidential election. See who it is HERE. |
09/12/2023
6:30 AM | Amgen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2023
8:12 AM | Amgen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/01/2023
8:25 AM | Amgen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/21/2023
6:36 PM | Amgen (Issuer)
Busch Matthew C. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/11/2023
5:13 PM | Amgen (Issuer)
Gordon Murdo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/10/2023
7:55 PM | Amgen (Issuer)
Drake Michael V (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/10/2023
7:56 PM | Amgen (Issuer)
ISHRAK OMAR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/10/2023
7:57 PM | Amgen (Issuer)
HOLLEY CHARLES M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/10/2023
2:18 PM | Amgen (Subject)
Gordon Murdo (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
